Fabry disease - a genetically conditioned extremely rare disease with a very unusual course
- PMID: 35261850
- PMCID: PMC8898388
- DOI: 10.5582/irdr.2021.01132
Fabry disease - a genetically conditioned extremely rare disease with a very unusual course
Abstract
Fabry disease (FD) is a rare lysosomal storage disease. FD is caused by the presence of a deleterious mutation in the GLA gene encoding the enzyme alpha galactosidase A (αGAL A) on the X chromosome. The accumulation of Gb3 and lyso-GL-3 in nerve fiber cells, endothelium, vascular muscle cells, mesangial cells, podocytes, renal tubular epithelial cells and cardiomyocytes is the most important pathogenetic factor. The rate of disease progression depends on residual conserved enzymatic activity. In this article we present an example of a 25-year-old patient with FD with an initial asymptomatic course. The first manifestation of FD developed in the third decade of life. These include high blood pressure, urinary changes and grade V renal failure, requiring renal replacement therapy. The diagnosis was made very late, when renal failure and cerebro-cardiac complications occurred, including stroke and dangerous cardiac tamponade.
Keywords: cardiovascular complications; fabry disease; renal failure.
2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Fabry J. "Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)". Archiv für Dermatologie und Syphilis. 1898; 43:187-200. doi:10.1007/bf01986897. ISSN 0340-3696. S2CID 33956139. (in German)
-
- Anderson W. A Case of "Angeio-Keratoma". Br J Dermatol. 1898; 10:113-117.
-
- Chimenti C, Scopelliti F, Vulpis E, Tafani M, Villanova L, Verardo R, De Paulis R, Russo MA, Frustaci A. Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy. Hum Pathol. 2015; 46:1760-1768. - PubMed
-
- Rozenfeld PA, de Los Angeles Bolla M, Quieto P, Pisani A, Feriozzi S, Neuman P, Bondar C. Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis. Mol Genet Metab. 2020; 129:132-141. - PubMed
-
- McGovern MM, Desnick RJ. Lysosomal storage diseases. Cecil Textbook of Medicine. In: Goldman L, editor. 21st ed. St. Louis: W.B. Saunders Company; 2000. pp. 1104-1107.